JP5053277B2 - Ｂｎｃｔに有用なホウ素化合物 - Google Patents

Ｂｎｃｔに有用なホウ素化合物 Download PDF

Info

Publication number
JP5053277B2
JP5053277B2 JP2008526905A JP2008526905A JP5053277B2 JP 5053277 B2 JP5053277 B2 JP 5053277B2 JP 2008526905 A JP2008526905 A JP 2008526905A JP 2008526905 A JP2008526905 A JP 2008526905A JP 5053277 B2 JP5053277 B2 JP 5053277B2
Authority
JP
Japan
Prior art keywords
tumor
compound
formula
boron
tumors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2008526905A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009504732A (ja
JP2009504732A5 (https=
Inventor
ラーシュ−インゲ・オルソン
エルヴァン・アルゼル
アーネ・エーク
Original Assignee
ハマーカップ・アーベー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ハマーカップ・アーベー filed Critical ハマーカップ・アーベー
Publication of JP2009504732A publication Critical patent/JP2009504732A/ja
Publication of JP2009504732A5 publication Critical patent/JP2009504732A5/ja
Application granted granted Critical
Publication of JP5053277B2 publication Critical patent/JP5053277B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/69—Boron compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds
    • C07F5/027—Organoboranes and organoborohydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
    • C07F5/02—Boron compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Radiation-Therapy Devices (AREA)
JP2008526905A 2005-08-19 2006-08-17 Ｂｎｃｔに有用なホウ素化合物 Expired - Fee Related JP5053277B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
SE0501847-8 2005-08-19
SE0501847 2005-08-19
SE0501903-9 2005-08-30
SE0501903A SE528407C2 (sv) 2005-08-19 2005-08-30 Borföreningar användbara vid BNCT
PCT/SE2006/000952 WO2007021234A1 (en) 2005-08-19 2006-08-17 Boron compounds useful in bnct

Publications (3)

Publication Number Publication Date
JP2009504732A JP2009504732A (ja) 2009-02-05
JP2009504732A5 JP2009504732A5 (https=) 2009-09-24
JP5053277B2 true JP5053277B2 (ja) 2012-10-17

Family

ID=37310298

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008526905A Expired - Fee Related JP5053277B2 (ja) 2005-08-19 2006-08-17 Ｂｎｃｔに有用なホウ素化合物

Country Status (8)

Country Link
US (1) US8183247B2 (https=)
EP (1) EP1915381B1 (https=)
JP (1) JP5053277B2 (https=)
CN (1) CN101268085B (https=)
RU (1) RU2423368C2 (https=)
SE (1) SE528407C2 (https=)
TW (1) TWI376381B (https=)
WO (1) WO2007021234A1 (https=)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007026701A1 (de) * 2007-06-01 2008-12-04 Universität Leipzig Neue chemische Verbindungen, deren Herstellung und deren Verwendung
CN101713740B (zh) * 2009-12-31 2012-05-02 中国原子能科学研究院 分光光度测量生物样品中bnct药物里硼含量的方法
CN104151339B (zh) * 2013-05-17 2017-05-03 中国科学院近代物理研究所 含硼吖啶衍生物、其制备方法和应用
JP6360113B2 (ja) * 2016-07-28 2018-07-18 ステラファーマ株式会社 ホウ素含有化合物
KR101903693B1 (ko) * 2016-11-28 2018-10-04 가천대학교 산학협력단 BSH 합성을 위한 티오피롤리딘을 이용한 Na2[B12H12] 반응
JP7154528B2 (ja) * 2017-08-25 2022-10-18 国立大学法人東京工業大学 ホウ素含有葉酸誘導体
WO2020180390A1 (en) * 2019-03-04 2020-09-10 TAE Life Sciences Borylated amino acid compositions for use in boron neutron capture therapy and methods thereof
CN112358494B (zh) * 2020-04-09 2021-09-28 南京大学 一种基于吖啶的碳硼烷衍生物及其在生物显影中的应用
CN112442095B (zh) * 2020-12-01 2022-07-22 上海科黛生物科技有限公司 一种维生素b12的精制方法及所得产品的应用
CN112979686B (zh) * 2021-02-08 2022-04-08 北京大学 一种新型硼携带剂、制备方法及其药物制剂
CN116874515B (zh) * 2023-05-10 2025-03-14 重庆高硼生物科技有限公司 一种氨基酸-bsh靶向杂合体化合物及其制备方法和应用
WO2025165163A1 (ko) * 2024-01-31 2025-08-07 (주)클리켐바이오 붕소중성자포획치료용 알부민 나노플랫폼 및 이를 포함하는 붕소중성자포획치료용 조성물

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5272250A (en) 1992-07-10 1993-12-21 Spielvogel Bernard F Boronated phosphoramidate compounds
US6180766B1 (en) 1993-12-02 2001-01-30 Raymond F. Schinazi Nucleosides and oligonucleotides containing boron clusters
CN1124821A (zh) * 1994-02-14 1996-06-19 肖冠英 同步齿带半潜传动全贯流水电机组
US5630786A (en) * 1994-06-27 1997-05-20 Ionix Corporation Boron neutron capture enhancement of fast neutron therapy
JP2685128B2 (ja) * 1995-07-21 1997-12-03 東北大学長 カルボラン含有ガドリニウム−ｄｔｐａ錯体、その中間体、およびこれらの製造方法
US6093382A (en) * 1998-05-16 2000-07-25 Bracco Research Usa Inc. Metal complexes derivatized with folate for use in diagnostic and therapeutic applications
DE19905094C1 (de) 1999-02-01 2000-10-12 Schering Ag Gadolinium (III)-Komplexe sowie ihre Verwendung für Zweischritt Strahlentherapieformen und diese enthaltende pharmazeutische Mittel
JP2001233883A (ja) * 2000-02-22 2001-08-28 Okayama Pref Gov Shin Gijutsu Shinko Zaidan カゴ状ホウ素化合物担持ポルフィリン錯体
EP1364954A4 (en) 2001-02-09 2009-10-28 Hiroyuki Kagechika Dicarba closo DODECARBORANDERIVATE
CA2555597C (en) * 2004-02-13 2016-06-14 The University Of British Columbia Radiolabeled compounds and compositions, their precursors and methods for their production
JP2005343858A (ja) * 2004-06-07 2005-12-15 Mebiopharm Co Ltd ホウ素イオンクラスター脂質及びこれを用いたリポソーム
JP2006096870A (ja) * 2004-09-29 2006-04-13 Stella Chemifa Corp ホウ素含有化合物

Also Published As

Publication number Publication date
JP2009504732A (ja) 2009-02-05
CN101268085A (zh) 2008-09-17
TWI376381B (en) 2012-11-11
RU2008110472A (ru) 2009-09-27
EP1915381B1 (en) 2013-04-10
US20090227539A1 (en) 2009-09-10
EP1915381A1 (en) 2008-04-30
EP1915381A4 (en) 2011-02-09
SE0501903L (sv) 2006-11-07
CN101268085B (zh) 2012-06-20
RU2423368C2 (ru) 2011-07-10
US8183247B2 (en) 2012-05-22
WO2007021234A1 (en) 2007-02-22
TW200740833A (en) 2007-11-01
SE528407C2 (sv) 2006-11-07

Similar Documents

Publication Publication Date Title
ES2804101T3 (es) Compuestos de 4-amino-imidazoquinolina
KR102472198B1 (ko) Pi3k 베타 저해제로서의 아자벤즈이미다졸 유도체
JP5053277B2 (ja) Ｂｎｃｔに有用なホウ素化合物
KR20180116307A (ko) Prmt5 저해제로 사용하기 위한 치환 뉴클레오사이드 유사체
TW201444838A (zh) 吡啶並嘧啶類衍生物、其製備方法及其在醫藥上的應用
KR20180069132A (ko) 결정질의 (8s,9r)-5-플루오로-8-(4-플루오로페닐)-9-(1-메틸-1h-1,2,4-트리아졸-5-일)-8,9-디하이드로-2h-피리도[4,3,2-de]프탈라진-3(7h)-온 토실레이트 염
CN116917288B (zh) 一种7,9-二氢嘌呤衍生物及其制药用途
JP2019527701A (ja) Ｆｇｆｒ４阻害剤並びにその製造方法及び使用
CN104557871B (zh) 具有螺环取代基的芳基吗啉类化合物，其制备方法和用途
JP2018503634A (ja) サイクリン依存性タンパク質キナーゼインヒビターのヒドロキシエチルスルホン酸塩、その結晶形およびその製造方法
CN101638389A (zh) 一种含萘酰亚胺结构的多胺衍生物及其制备方法和应用
EP3847175B1 (en) Crystalline forms of a phosphoinositide 3-kinase (pi3k) inhibitor
CN104557913A (zh) 吡啶并嘧啶类化合物，其制备方法和用途
JP6586463B2 (ja) ＰＩ３Ｋβ阻害剤としての複素環連結イミダゾピリダジン誘導体
KR20260006628A (ko) 섬유아세포 활성화 단백질을 표적화하는 리간드
JP7149854B2 (ja) Ｐｉ３ｋ ｂｅｔａ阻害薬としての二環式ピリジン、ピラジンおよびピリミジン誘導体
CN1616428A (zh) 苊并杂环类化合物及其诱导细胞凋亡和抗肿瘤的应用
CN1882365A (zh) 金属三羰基络合物作为放射治疗化学毒性剂的用途
JP2023549273A (ja) プロテインキナ－ゼ阻害剤としての置換されたピロロ［２，３－ｂ］ピリジン及びピラゾロ［３，４－ｂ］ピリジン誘導体
CN116120254B (zh) 13,14-双一氧化氮供体-β-榄香烯衍生物及其制备和应用
WO2025247236A1 (en) Pt (iv) chemotherapeutic prodrug and controlled release thereof for treatment of tumors
CN110183471B (zh) 一种哌嗪类衍生物及制备方法及应用
WO2026026904A1 (en) The crystalline forms of a compound
JP2026504054A (ja) ピラゾール類誘導体、その薬学的に許容される塩、立体異性体、医薬組成物及び使用
HK40107642A (en) Crystalline forms of a phosphoinositide 3-kinase (pi3k) inhibitor

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090807

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090807

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120313

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120606

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120703

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120725

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

Ref document number: 5053277

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150803

Year of fee payment: 3

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

LAPS Cancellation because of no payment of annual fees